PBLS market overview

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

Latest price: $33.32
Daily change: +0.00%
Market state: closed
As of: 2026-09-23 19:56:31 ET

The interactive chart loads with current market data when StockStorm starts.

Market information is provided for research and visualization and is not investment advice.